ChiCTR-OPC-14005353
正在进行
/
/
/
2014-09-11
/
/
Patients with post-traumatic chronic wrist pain, with imaging and previous arthroscopic evidence of wrist carpal bone chondral defects who opt for active treatment
臨床試驗研究 –「自體間質幹細胞治療腕關節軟骨缺損」
臨床試驗研究 –「自體間質幹細胞治療腕關節軟骨缺損」
自體間質幹細胞治療腕關節軟骨缺損
单臂
治疗新技术
N/A
/
The Chinese University of Hong Kong
/
20
/
2014-10-01
1990-01-01
/
1. Wrist pain of mechanical origin(post-traumatic); 2. The pain cannot be relieved by treating other underlying defects other than carpal affections; 3. Patients with imaging and previous arthroscopic evidence of wrist carpal bone chondral defects; 4. Absence of any local or general infection; 5. Hematologic and biochemical analyses with no significant alterations that contraindicate intervention; 6. Patient who is able to understand the nature the study and provide informed written consent.；
请登录查看1. Age older than 75 or younger than 18 years old or legally dependent; 2. Patients with past history of hematologic disorders; 3. Signs of infection or positive serology for HIV, HBV, HCV, or syphilis; 4. Congenital or acquired diseases leading to significant wrist deformities that may interfere with cell application or interpretation of results; 5. Pregnancy or breast, feeding, Neoplasia, Immunosuppression, Participation in another clinical trial or treatment with another investigational product within 30 days before inclusion in the study; 6. Patients with alcoholism/drug abuse; 7. Other medical conditions that may discourage participation in the study.；
请登录查看Dr. WL Tse
/
Dr. WL Tse的其他临床试验
Department of Orthopaedics and Traumatoloy, Prince of Wales Hospital, Shatin, Hong Kong的其他临床试验
最新临床资讯
-
飞眸医疗首例人体临床试验（FIH）成功开展，国产飞秒屈光设备竞逐540亿屈光市场
动脉网-最新2026-09-10
-
和铂医药：超长效靶向TSLP抗体哮喘二期临床取得阳性结果，三期临床已启动
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
医药笔记2026-09-09
-
动脉网-最新2026-09-09
-
药明康德2026-09-09
-
一度医药2026-09-08
-
阿斯利康中国2026-09-08
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 20 8
-
摩熵咨询 20 11
-
摩熵咨询 34 56
-
颁布机构：国家药品监督管理局 2026-09-10
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-09-26
-
2026-09-26
-
2026-09-26
-
摩熵咨询 35 71
-
摩熵咨询 28 60
-
摩熵咨询 34 42
-
颁布机构：国家市场监督管理总局 2026-09-18
-
颁布机构：国家市场监督管理总局 2026-09-17
-
颁布机构：国家市场监督管理总局 2026-08-10